Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
EXAS Quote, Financials, Valuation and Earnings
Last price:
$52.19
Seasonality move
:
0.46%
Day range:
$52.20 - $53.79
52-week range:
$39.97 - $72.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.52x
P/B ratio:
4.22x
Volume:
1.6M
Avg. volume:
2.7M
1-year change:
8.05%
Market cap:
$10.1B
Revenue:
$2.8B
EPS (TTM):
-$5.51
Earnings Data
Next earnings date for EXAS
Aug 06
2025
Most recent earnings per share
-$0.54
Missed by $0.45
(May 1/2025)
Consensus Estimate
-$0.10
(May 1/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EXAS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $796.7M | -- | -- | $0.14 | -- |
| 08/06/2025 | Q2 | $774.7M | -- | -- | $0.05 | -- |
| 05/01/2025 | Q1 | $688.6M | $706.8M | -$0.54 | -$0.10 | -$0.45 |
| 02/19/2025 | Q4 | $701.5M | $713.4M | -$4.67 | -$0.19 | -$4.48 |
| 11/05/2024 | Q3 | $717M | $708.7M | -$0.21 | -$0.10 | -$0.11 |
| 07/31/2024 | Q2 | $690.1M | $699.3M | -$0.09 | -$0.24 | $0.15 |
| 05/08/2024 | Q1 | $626.8M | $637.5M | -$0.60 | -$0.41 | -$0.19 |
| 02/21/2024 | Q4 | $639.7M | $646.9M | -$0.27 | -$0.36 | $0.09 |
| 11/01/2023 | Q3 | -- | -- | $0.00 | -$0.43 | $0.44 |
| 08/01/2023 | Q2 | -- | -- | -$0.45 | -$0.41 | -$0.04 |
| 05/09/2023 | Q1 | -- | -- | -$0.42 | -$0.66 | $0.24 |
| 02/21/2023 | Q4 | -- | -- | -$0.72 | -$0.78 | $0.06 |
| 11/03/2022 | Q3 | -- | -- | -$0.84 | -$1.05 | $0.21 |
| 08/02/2022 | Q2 | -- | -- | -$0.94 | -$1.04 | $0.10 |
| 04/26/2022 | Q1 | -- | -- | -$1.04 | -$1.04 | -- |
| 02/22/2022 | Q4 | -- | -- | -$1.28 | -$0.88 | -$0.40 |
| 11/02/2021 | Q3 | -- | -- | -$0.97 | -$0.83 | -$0.14 |
| 07/28/2021 | Q2 | -- | -- | -$1.03 | -$0.72 | -$0.31 |
| 05/04/2021 | Q1 | -- | -- | -$0.18 | -$0.94 | $0.76 |
| 02/16/2021 | Q4 | -- | -- | -$2.79 | -$0.26 | -$2.53 |
| 10/29/2020 | Q3 | -- | -- | -$1.46 | -$0.57 | -$0.89 |
| 07/30/2020 | Q2 | -- | -- | -$0.58 | -$0.65 | $0.07 |
| 05/06/2020 | Q1 | -- | -- | -$0.71 | -$0.52 | -$0.19 |
| 02/11/2020 | Q4 | -- | -- | $0.54 | -$0.36 | $0.90 |
| 10/29/2019 | Q3 | -- | -- | -$0.31 | -$0.41 | $0.10 |
| 07/30/2019 | Q2 | -- | -- | -$0.30 | -$0.56 | $0.26 |
| 04/30/2019 | Q1 | -- | -- | -$0.66 | -$0.65 | -$0.01 |
| 02/21/2019 | Q4 | -- | -- | -$0.44 | -$0.48 | $0.04 |
| 10/30/2018 | Q3 | -- | -- | -$0.37 | -$0.43 | $0.06 |
| 08/01/2018 | Q2 | -- | -- | -$0.30 | -$0.33 | $0.03 |
| 04/26/2018 | Q1 | -- | -- | -$0.33 | -$0.38 | $0.05 |
| 02/22/2018 | Q4 | -- | -- | -$0.18 | -$0.24 | $0.06 |
| 10/31/2017 | Q3 | -- | -- | -$0.23 | -$0.30 | $0.07 |
| 07/25/2017 | Q2 | -- | -- | -$0.27 | -$0.35 | $0.08 |
| 04/27/2017 | Q1 | -- | -- | -$0.32 | -$0.41 | $0.09 |
| 02/21/2017 | Q4 | -- | -- | -$0.34 | -$0.40 | $0.06 |
| 10/26/2016 | Q3 | -- | -- | -- | -- | -- |
| 07/26/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/03/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/24/2016 | Q4 | -- | -- | -- | -- | -- |
| 10/29/2015 | Q3 | -- | -- | -- | -- | -- |
Exact Sciences Earnings Questions
-
How Much did Exact Sciences Generate in Revenue Last Quarter?
Exact Sciences reported $706.8M worth of top line sales in its most recent quarter.
-
Did Exact Sciences Beat Earnings Last Quarter?
Exact Sciences announced earnings per share of -$0.54 which represents a miss of analyst forecast a -$0.10 per share.
-
Is Exact Sciences Profitable?
Exact Sciences reported $500.5M that represents $2.68 per share over the last quarter.
-
What is the Analyst Consensus for Exact Sciences EPS Next Year?
Exact Sciences's earnings are forecast to decrease from -$5.59 per share to -$0.57 per share next year representing a decrease of -99.99%.
-
When is Exact Sciences's Earnings Date?
Exact Sciences's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
